All Curated Mutation Sites in HCMV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCMV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
gB
  
IE2
  
Pol
  
protease
  
UL18
  
UL27
  
UL54
  
UL56
  
UL89
  
UL97
  
US28
  

Keyword: Cytomegalovirus infections-33966176
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 33966176 A582V
UL97
UL97
Cytomegalovirus infections
C
L
 View
2 33966176 A614S
UL54
UL54
Cytomegalovirus infections
C
L
 View
3 33966176 D514N
UL54
UL54
Cytomegalovirus infections
C
L
 View
4 33966176 E353Q
UL54
UL54
Cytomegalovirus infections
C
L
 View
5 33966176 G604S
UL54
UL54
Cytomegalovirus infections
C
L
 View
6 33966176 G633F
UL97
UL97
Cytomegalovirus infections
C
L
 View
7 33966176 G677D
UL54
UL54
Cytomegalovirus infections
C
L
 View
8 33966176 G678S
UL97
UL97
Cytomegalovirus infections
C
L
 View
9 33966176 G878E
UL54
UL54
Cytomegalovirus infections
C
L
 View
10 33966176 L999I
UL54
UL54
Cytomegalovirus infections
C
L
 View
11 33966176 M727I
UL54
UL54
Cytomegalovirus infections
C
L
 View
12 33966176 R876W
UL54
UL54
Cytomegalovirus infections
C
L
 View
13 33966176 S633F
UL54
UL54
Cytomegalovirus infections
C
L
 View
14 33966176 T691A
UL54
UL54
Cytomegalovirus infections
C
L
 View
15 33966176 T760X
UL54
UL54
Cytomegalovirus infections
C
L
 View
16 33966176 T885M
UL54
UL54
Cytomegalovirus infections
C
L
 View
17 33966176 V973A
UL54
UL54
Cytomegalovirus infections
C
L
 View
Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.